DUBLIN--(BUSINESS WIRE)--The "Structural Heart Devices Market: Analysis By Product, By Procedure, By End User, By Region Size and Trends and Forecast up to 2029" report has been added to ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Dec. 12, 2024 /PRNewswire/ -- The global Structural Heart Devices market is expected to grow to ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global structural heart disease treatment devices market since 2018 and the market is poised to grow by USD 5.61 billion during 2020-2024 at ...

St. Luke’s University Health Network has reached an important milestone in advanced heart care. Members of St. Luke’s ...

Investors are showing growing interest in the rapidly expanding structural heart device market, which is expected to witness a compound annual growth rate (CAGR) of 13.5% between 2025 and 2033, ...

It was a big news year for structural heart disease. For tricuspid regurgitation, two devices were approved in quick succession by the US Food and Drug Administration, then later in 2024, long-awaited ...

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular ...

Michelle Judy, the structural heart coordinator, holds up the box for the WATCHMAN FLX Pro Device as interventional cardiologist Dr. Fernando Boccalandro explains what it does at Medical Center ...

Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of Fox 17. February is Heart Month, and Trinity Health is taking this opportunity to ...

Cardiovascular disease is the biggest driver of health care spending in most countries, creating more opportunities for future growth. According to Mordor Intelligence, the cardiovascular devices ...